Long-term results of cornea collagen cross-linking with riboflavin for keratoconus

Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improv...

Descripción completa

Detalles Bibliográficos
Autor principal: Agrawal, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Symposium: Keratoconus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775082/
https://www.ncbi.nlm.nih.gov/pubmed/23925332
http://dx.doi.org/10.4103/0301-4738.116072
_version_ 1782284574994202624
author Agrawal, Vinay
author_facet Agrawal, Vinay
author_sort Agrawal, Vinay
collection PubMed
description Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improvement in visual acuity. In the light of currently available data we can thus say that CXL is a safe procedure that is successful in arresting keratoconus.
format Online
Article
Text
id pubmed-3775082
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37750822013-09-18 Long-term results of cornea collagen cross-linking with riboflavin for keratoconus Agrawal, Vinay Indian J Ophthalmol Symposium: Keratoconus Corneal collagen cross-linking with riboflavin and UVA light (CXL) is the only method designed to arrest the progression of keratoconus. Visual improvement generally starts 3 months after treatment. Reduction is coma seen on aberrometry in early postoperative phase is also responsible for the improvement in visual acuity. In the light of currently available data we can thus say that CXL is a safe procedure that is successful in arresting keratoconus. Medknow Publications & Media Pvt Ltd 2013-08 /pmc/articles/PMC3775082/ /pubmed/23925332 http://dx.doi.org/10.4103/0301-4738.116072 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium: Keratoconus
Agrawal, Vinay
Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title_full Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title_fullStr Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title_full_unstemmed Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title_short Long-term results of cornea collagen cross-linking with riboflavin for keratoconus
title_sort long-term results of cornea collagen cross-linking with riboflavin for keratoconus
topic Symposium: Keratoconus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775082/
https://www.ncbi.nlm.nih.gov/pubmed/23925332
http://dx.doi.org/10.4103/0301-4738.116072
work_keys_str_mv AT agrawalvinay longtermresultsofcorneacollagencrosslinkingwithriboflavinforkeratoconus

Ejemplares similares